Optometrists in Laingsburg, MI Accepting Medicare
2 Optometrists found. Showing 1 - 2
 Laingsburg Eye Care P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 252 E Grand River Rd, Laingsburg, MI 48848 Phone: 517-651-6608 Fax: 517-651-6603 |
 Dr. Marsha A Brandon, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 252 E Grand River Rd, Laingsburg, MI 48848 Phone: 517-651-6608 Fax: 517-651-6608 |
News Archive
Pretreating polycarbonate plastic is an eco-friendly way of waste disposal: Research
Just as cooking helps people digest food, pretreating polycarbonate plastic - source of a huge environmental headache because of its bisphenol A (BPA) content - may be the key to disposing of the waste in an eco-friendly way, scientists have found. Their new study is in ACS' Biomacromolecules, a monthly journal.
Dietary flaxseed may help prevent colorectal tumors
New research from South Dakota State University offers evidence that including flax in the diet may help prevent colorectal tumors or keep tumors from growing as quickly when they do form.
Project SEARCH interns become part of NIH fabric
When Project SEARCH interns enter the National Institutes of Health campus in Bethesda, Md., they are immediately recognizable—from their matching, sky-blue polo shirts to their smiling faces. "People know these interns," says Steve Blanks, program director at SEEC, Seeking Equality, Empowerment and Community for People with Developmental Disabilities.
AANF changes name to American Brain Foundation
The American Academy of Neurology Foundation is now the American Brain Foundation. The name change is part of an overall re-branding campaign as the organization repositions itself to become the world's leader in raising money for research to cure brain diseases, such as Alzheimer's disease, stroke, Parkinson's disease, autism, and epilepsy.
Celgene reports initial data from investigator-initiated study of REVLIMID
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
› Verified 3 days ago